Extended P2Y12 inhibitor monotherapy found to benefit high-risk acute coronary syndrome patients

heart
Source: Read Full Article

Related posts:
  1. “Returning to London for the first time in 7 months was more stressful than I ever expected”
  2. AstraZeneca vaccine blood clots: Scientists have discovered a crucial piece of the puzzle
  3. New tumor cell tracking system aims to understand cancer treatment resistance
  4. Receptor gene FIBCD1 newly identified in neuro-developmental disorders